BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8100774)

  • 21. Emerging views on integrin signaling via Rac1 during invasin-promoted bacterial uptake.
    Wong KW; Isberg RR
    Curr Opin Microbiol; 2005 Feb; 8(1):4-9. PubMed ID: 15694850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to CD44 trigger effector functions of human T cell clones.
    Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
    J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
    Adamthwaite D; Cooley MA
    Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire.
    Batten P; Heaton T; Fuller-Espie S; Lechler RI
    J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of cytotoxicity used by human peripheral blood CD4+ and CD8+ T cell subsets. The role of granule exocytosis.
    Smyth MJ; Ortaldo JR
    J Immunol; 1993 Jul; 151(2):740-7. PubMed ID: 8101537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yersinia enterocolitica: subversion of adaptive immunity and implications for vaccine development.
    Autenrieth SE; Autenrieth IB
    Int J Med Microbiol; 2008 Jan; 298(1-2):69-77. PubMed ID: 17702651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential activation of CD8+ T cells by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1993 Jul; 151(2):668-77. PubMed ID: 8335902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of CD4+ T helper cell clones in human melanoma.
    Goedegebuure PS; Lee KY; Matory YL; Peoples GE; Yoshino I; Eberlein TJ
    Cell Immunol; 1994 Jun; 156(1):170-9. PubMed ID: 7911074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural requirements for mucosal vascular addressin binding to its lymphocyte receptor alpha 4 beta 7. Common themes among integrin-Ig family interactions.
    Briskin MJ; Rott L; Butcher EC
    J Immunol; 1996 Jan; 156(2):719-26. PubMed ID: 8543825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein.
    Leong JM; Fournier RS; Isberg RR
    EMBO J; 1990 Jun; 9(6):1979-89. PubMed ID: 1693333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very late antigen 4-dependent adhesion and costimulation of resting human T cells by the bacterial beta 1 integrin ligand invasin.
    Ennis E; Isberg RR; Shimizu Y
    J Exp Med; 1993 Jan; 177(1):207-12. PubMed ID: 8418202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins.
    Frankel G; Lider O; Hershkoviz R; Mould AP; Kachalsky SG; Candy DC; Cahalon L; Humphries MJ; Dougan G
    J Biol Chem; 1996 Aug; 271(34):20359-64. PubMed ID: 8702771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association.
    Dersch P; Isberg RR
    EMBO J; 1999 Mar; 18(5):1199-213. PubMed ID: 10064587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct mechanisms of integrin binding by Yersinia pseudotuberculosis adhesins determine the phagocytic response of host macrophages.
    Hudson KJ; Bliska JB; Bouton AH
    Cell Microbiol; 2005 Oct; 7(10):1474-89. PubMed ID: 16153246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.